Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Betere behandeling van prostaatkanker door combinatie van bestralingstechnieken
feb 2017 | Radiotherapie, Uro-oncologie